Several signaling mechanisms for regulating PTGS2 in cervical cancer have been validated, including the EGF and nuclear factor κB (NF-κB) pathways [35], and PAR2 through an EGFR-dependent mechanism [34]. This evidence concerns the gene EGFR and cervical cancer.